Success Metrics

Clinical Success Rate
92.9%

Based on 39 completed trials

Completion Rate
93%(39/42)
Active Trials
6(11%)
Results Posted
33%(13 trials)
Terminated
3(5%)

Phase Distribution

Ph not_applicable
3
5%
Ph phase_4
18
32%
Ph phase_1
13
23%
Ph early_phase_1
2
4%
Ph phase_3
7
12%
Ph phase_2
13
23%

Phase Distribution

15

Early Stage

13

Mid Stage

25

Late Stage

Phase Distribution56 total trials
Early Phase 1First-in-human
2(3.6%)
Phase 1Safety & dosage
13(23.2%)
Phase 2Efficacy & side effects
13(23.2%)
Phase 3Large-scale testing
7(12.5%)
Phase 4Post-market surveillance
18(32.1%)
N/ANon-phased studies
3(5.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

39 of 45 finished

Non-Completion Rate

13.3%

6 ended early

Currently Active

6

trials recruiting

Total Trials

57

all time

Status Distribution
Active(7)
Completed(39)
Terminated(6)
Other(5)

Detailed Status

Completed39
Recruiting5
unknown4
Terminated3
Withdrawn3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
57
Active
6
Success Rate
92.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (3.6%)
Phase 113 (23.2%)
Phase 213 (23.2%)
Phase 37 (12.5%)
Phase 418 (32.1%)
N/A3 (5.4%)

Trials by Status

terminated35%
not_yet_recruiting12%
withdrawn35%
active_not_recruiting12%
recruiting59%
completed3968%
unknown47%
suspended12%

Recent Activity

Clinical Trials (57)

Showing 20 of 57 trialsScroll for more
NCT03427736

Anesthetics and Analgesics in Children

Recruiting
NCT05324358Phase 3

Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy

Suspended
NCT05336266Early Phase 1

A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma

Active Not Recruiting
NCT06513208Phase 4

Ketorolac Effects on Post-operative Pain and Lumbar Fusion

Recruiting
NCT03513770Early Phase 1

Autonomic Control of the Circulation and VDR

Recruiting
NCT05641363Phase 3

Comparison of Ketorolac at Three Doses in Children With Acute Pain

Completed
NCT03913702Phase 2

Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement

Terminated
NCT03453541Phase 4

Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy

Terminated
NCT04733326Phase 1

Evaluation of Post-operative Pain and Expression of IL-8 Using Ketolac or Cryoirrigation as a Final Flush in Single Visit Endodontic Treatment in Teeth With Symptomatic Irreversible Pulpitis and Apical Periodontitis.Randomized Clinical Trial.

Completed
NCT06395428Phase 4

Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department

Recruiting
NCT06160778Phase 3

Intravenous Ketorolac Vs. Morphine In Children With Acute Abdominal Pain

Recruiting
NCT06273813Phase 1

Treatment of Topical Ketorolac Gel in Acute Gouty Flare

Not Yet Recruiting
NCT04666701Phase 2

Efficacy and Safety of Escócia Association in the Treatment of Acute Pain

Withdrawn
NCT05382546Phase 1

A Pharmacokinetic Study of Intravenous NTM-001 in Healthy Chinese Subjects

Completed
NCT04439396Phase 1

Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use

Completed
NCT04554862Phase 4

The Analgesic Efficacy of Magnesium and Ketorolac in Ultrasound Supraclavicular Block

Completed
NCT04939987Phase 2

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

Withdrawn
NCT01471886Phase 3

Comparison Of Ketorolac Tromethamine Versus Naproxen For Moderate to Severe Back Pain Treatment

Completed
NCT01471899Phase 3

Comparison Of Ketorolac Tromethamine Oral Drops Versus Naproxen For Moderate to Severe Back Pain Treatment

Completed
NCT02902770Phase 4

Intravenous Lidocaine and Ketorolac for Pain Management

Completed

Drug Details

Intervention Type
DRUG
Total Trials
57